结论纳洛酮联合门冬氨酸鸟氨酸治疗肝性脑病疗效确切。
Conclusion Naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy was exactly effective.
目的：观察门冬氨酸鸟氨酸治疗亚临床肝性脑病的临床疗效及安全性。
Objective: To evaluate the effect and safety of L-ornithine-L-aspartate on Subclinical Hepatic Encephalopathy.
目的 应用门冬氨酸鸟氨酸对肝性脑病的临床疗效及安全性进行观察。
Objective To evaluate the clinical efficacy and safety of L-ornithine-L-aspartate treating the patients with hepatic encephalopathy.
探讨纳洛酮联合门冬氨酸鸟氨酸治疗肝硬化并肝性脑病患者的临床疗效。
To explore the clinical effectiveness of naloxone and ornithine aspartate in the treatment of the liver cirrhosis and hepatic encephalopathy.
目的探讨门冬氨酸鸟氨酸在乙肝病毒感染的恶性淋巴瘤放化疗中的保护作用。
Objective To explore the protective effect of L-Ornithine-L-Aspartate(LOLA) assisted with chemoradiotherapy in patient of lymphoma with hepatitis B virus(HBV).
目的通过大鼠肝纤维化动物模型，研究门冬氨酸鸟氨酸防止肝纤维化的作用。
Objective To study the role of ornithine aspartate on preventing of liver fibrosis through the rat liver fibrotic model.
结果治疗组经门冬氨酸鸟氨酸治疗后神志改变、ALT、AST明显优于治疗前（P<0.05）。
Results One week after the treatment, the liver function (ALT, AST) and mind change of patients differed statistically significantly from that before the treatment (P<0.05).
目的观察左旋门冬氨酸-鸟氨酸治疗肝硬化合并肝性脑病的临床疗效。
Objective To observe the therapeutic effects of L-ornithine-L-aspartate on liver cirrhosis complicated by hepatic encephalopathy.
目的评价门冬氨酸-鸟氨酸治疗黄疸型慢性病毒性肝炎的临床疗效。
Objective Aim To evaluate clinical efficacy of L-ornithine-L-aspartate in the management of icteric chronic viral hepatitis.
目的评价门冬氨酸-鸟氨酸治疗黄疸型慢性病毒性肝炎的临床疗效。
Objective Aim To evaluate clinical efficacy of L-ornithine-L-aspartate in the management of icteric chronic viral hepatitis.
应用推荐